Key Points
- James William Rogers, Tempus AI's CFO, sold 19,966 shares on Dec. 11 at an average of $73.20 (≈$1.46M), reducing his ownership by 15.22% to 111,250 shares valued at about $8.14M.
- Tempus AI reported revenue of $334.21M (up 84.7% YoY) and EPS of ($0.11) that beat estimates, but the stock is volatile and carries a MarketBeat consensus rating of Hold with an average target of $83.09.
Tempus AI, Inc. (NASDAQ:TEM - Get Free Report) CFO James William Rogers sold 19,966 shares of the business's stock in a transaction on Thursday, December 11th. The stock was sold at an average price of $73.20, for a total transaction of $1,461,511.20. Following the transaction, the chief financial officer owned 111,250 shares in the company, valued at approximately $8,143,500. The trade was a 15.22% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which can be accessed through the SEC website.
James William Rogers also recently made the following trade(s):
- On Tuesday, November 18th, James William Rogers sold 7,257 shares of Tempus AI stock. The shares were sold at an average price of $65.54, for a total transaction of $475,623.78.
Tempus AI Stock Performance
Shares of TEM opened at $70.61 on Friday. The company has a market cap of $12.56 billion, a PE ratio of -59.34 and a beta of 4.99. The firm has a 50-day moving average of $80.97 and a 200-day moving average of $73.39. Tempus AI, Inc. has a one year low of $31.36 and a one year high of $104.32. The company has a debt-to-equity ratio of 2.45, a current ratio of 3.28 and a quick ratio of 3.12.
Tempus AI (NASDAQ:TEM - Get Free Report) last issued its earnings results on Tuesday, November 4th. The company reported ($0.11) earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.16) by $0.05. Tempus AI had a negative net margin of 18.45% and a negative return on equity of 73.21%. The business had revenue of $334.21 million during the quarter, compared to the consensus estimate of $328.89 million. During the same period last year, the business posted ($0.46) EPS. Tempus AI's revenue was up 84.7% on a year-over-year basis. As a group, equities analysts forecast that Tempus AI, Inc. will post -6.15 earnings per share for the current year.
Institutional Investors Weigh In On Tempus AI
Hedge funds and other institutional investors have recently modified their holdings of the company. Allworth Financial LP boosted its position in shares of Tempus AI by 73.9% in the third quarter. Allworth Financial LP now owns 798 shares of the company's stock valued at $64,000 after acquiring an additional 339 shares during the period. IFP Advisors Inc raised its stake in Tempus AI by 140.1% in the 3rd quarter. IFP Advisors Inc now owns 4,274 shares of the company's stock worth $345,000 after purchasing an additional 2,494 shares in the last quarter. Swiss Life Asset Management Ltd bought a new stake in Tempus AI in the 3rd quarter valued at about $349,000. EMC Capital Management acquired a new position in shares of Tempus AI during the 3rd quarter worth approximately $297,000. Finally, Sunbelt Securities Inc. acquired a new position in shares of Tempus AI during the 3rd quarter worth approximately $52,000. Institutional investors and hedge funds own 24.22% of the company's stock.
Analysts Set New Price Targets
A number of analysts have recently issued reports on the company. Cowen cut Tempus AI from a "buy" rating to a "hold" rating in a research report on Tuesday, October 21st. Weiss Ratings reaffirmed a "sell (d-)" rating on shares of Tempus AI in a report on Wednesday, October 8th. BTIG Research upped their price objective on shares of Tempus AI from $96.00 to $105.00 and gave the company a "buy" rating in a report on Tuesday, November 25th. Guggenheim increased their price objective on shares of Tempus AI from $80.00 to $95.00 and gave the company a "buy" rating in a research report on Friday, September 26th. Finally, HC Wainwright reduced their target price on shares of Tempus AI from $98.00 to $89.00 and set a "buy" rating for the company in a report on Friday, November 7th. Seven research analysts have rated the stock with a Buy rating, seven have assigned a Hold rating and one has issued a Sell rating to the company's stock. According to MarketBeat, Tempus AI presently has an average rating of "Hold" and an average target price of $83.09.
Get Our Latest Analysis on Tempus AI
Tempus AI Company Profile
(
Get Free Report)
Tempus AI Inc is a technology company advancing precision medicine through the practical application of artificial intelligence principally in healthcare. The company provides AI-enabled precision medicine solutions to physicians to deliver personalized patient care and in parallel facilitates discovery, development and delivery of optimal therapeutics.
Featured Stories
This instant news alert was generated by narrative science technology and financial data from InsiderTrades.com in order to provide readers with the fastest and most accurate reporting. Please send any questions or comments about this story to [email protected].
